Related Experiment Video
Updated: Feb 2, 2026
Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
Published on: April 14, 2010
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved
Jimmy Van den Eynden1,2, Ganesh Umapathy1, Arghavan Ashouri1
1Department of Medical Biochemistry and Cell Biology, Sahlgrenska Academy, University of Gothenburg, SE-405 30 Göteborg, Sweden.
Abstract:
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that is a clinical target of major interest in cancer. Mutations and rearrangements in ALK trigger the activation of the encoded receptor and its downstream signaling pathways. ALK mutations have been identified in both familial and sporadic neuroblastoma cases as well as in 30 to 40% of relapses, which makes ALK a bona fide target in neuroblastoma therapy. Tyrosine kinase inhibitors (TKIs) that target ALK are currently in clinical use for the treatment of patients with ALK-positive non-small cell lung cancer. However, monotherapy with the ALK inhibitor crizotinib has been less encouraging in neuroblastoma patients with ALK alterations, raising the question of whether combinatorial therapy would be more effective. In this study, we established both phosphoproteomic and gene expression profiles of ALK activity in neuroblastoma cells exposed to first- and third-generation ALK TKIs, to identify the underlying molecular mechanisms and identify relevant biomarkers, signaling networks, and new therapeutic targets. This analysis has unveiled various important leads for novel combinatorial treatment strategies for patients with neuroblastoma and an increased understanding of ALK signaling involved in this disease.
Insights
Anaplastic lymphoma kinase (ALK) is a key target in neuroblastoma. This study explored ALK inhibitor combinations, revealing new therapeutic strategies and a deeper understanding of ALK signaling in neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Anaplastic lymphoma kinase (ALK) is a significant therapeutic target in various cancers, including neuroblastoma.
- ALK mutations and rearrangements are prevalent in neuroblastoma, particularly in relapsed cases, highlighting its importance in disease progression.
- Current ALK inhibitor monotherapy shows limited efficacy in neuroblastoma, necessitating exploration of alternative treatment strategies.
Purpose of the Study:
- To investigate the molecular mechanisms of anaplastic lymphoma kinase (ALK) signaling in neuroblastoma.
- To identify potential biomarkers and novel therapeutic targets for neuroblastoma by analyzing ALK activity under TKI treatment.
- To explore the efficacy of combinatorial therapies involving ALK inhibitors for neuroblastoma treatment.
Main Methods:
- Established phosphoproteomic and gene expression profiles of neuroblastoma cells.
- Exposed cells to first- and third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs).
- Analyzed signaling pathways, biomarkers, and molecular mechanisms associated with ALK activity.
Main Results:
- Uncovered critical insights into ALK signaling pathways in neuroblastoma.
- Identified potential biomarkers and signaling networks regulated by ALK.
- Provided a foundation for developing novel combinatorial treatment strategies for neuroblastoma.
Conclusions:
- Combinatorial therapy holds promise for treating neuroblastoma patients with ALK alterations.
- Enhanced understanding of ALK signaling pathways can guide the development of more effective neuroblastoma treatments.
- This research paves the way for improved therapeutic interventions targeting anaplastic lymphoma kinase (ALK) in neuroblastoma.
Related Concept Videos
01:42What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
01:36What is Gene Expression?
01:58Cell Specific Gene Expression
01:58Cell Specific Gene Expression
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:51mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability